In vitro technology bids for prestigious Innovation 10 prize

Kirkstall, an innovative Sheffield company, has launched a video in support of their bid to win a prestigious Technology Strategy Board prize. Their technology enables different human cell types to be grown in an interconnected way, using a microfluidic flow system. This ‘quasi vivo’ system more accurately reflects the way in which cells grow in the body, and hence provides more relevant results. We are delighted that Managing Director Dr Malcolm Wilkinson praised our campaign for safer medicines during the course of his video, and wish Kirkstall the best of luck! Winning the £100k prize would enable Kirkstall to develop their technology even further. Please view and rate their entry here (or here). Please note: as only scientific comments are requested, it is perfectly acceptable to vote without commenting!

Follow Us

Latest Blog Posts

New paper discusses  in silico New Approach Methodologies (NAMs) and increasing use of ‘big data’ to advance human relevant research

A new paper by Safer Medicines scientific consultant Rebecca Ram, Dr. Domenico Gadaleta of the Mario Negri Institute, Italy and Dr. Tim Allen of the MRC Toxicology Unit, Cambridge discusses the progress of in-silico methods in New Approach Methodologies (NAMs) as well as the increasing need for use of ‘big data’ and artificial intelligence (AI) […]

World Animal Free Research Day

One of our partner charities in the Alliance for Human Relevant Science is Animal Free Research UK. They have initiated an annual World Animal Free Research Day on the anniversary of their founding, 27th May. Our goals are very complementary: Animal Free Research UK’s vision is “To create a world where human diseases are cured faster without animal suffering”, while […]